Dr. Michael Lauer was on campus discussing NIH initiatives on Wednesday, June 13th. This seminar was sponsored by Provost Mark Tykocinski, MD and The Office of the Provost, TJU.
|Date, Time & Location||Seminar Title||Department||Speaker||Host|
|June 25, 2018
12 - 1 PM
Bluemle Life Science Building Room 101
|MECP2 is a Frequently Amplified Oncogene & a Possible Therapeutic Target||Biochemistry & Molecular Biology/Cancer Biology||Daniel Silver, MD, PhD||